Home -> Law Blog Directory -> Academic Blogs -> Legal Theory Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Academic
: Legal Theory BlogSarnoff on Patent Eligible Inventions
By Lawrence Solum
- The U.S. Supreme Court has continued to require that patentable subject matter eligibility determinations under Section 101 be made by reference to three historic, categorical exclusions, for scientific principles, natural phenomena, and abstract ideas, which must be treated as if already known even when newly discovered by the applicant. Various thoughtful scholars have alternatively urged that these exclusions from the patent system should be viewed restrictively or that eligibility decisions should be avoided. But these scholars under appreciate the benefits of categorical exclusions and particularly of treating them as if they were already known prior art, and in any event the Federal Circuit (reluctantly), the Patent and Trademark Office, and the public must now take up the difficult task of drawing lines between eligible inventions and ineligible applications of excluded discoveries.
This article supplies a history and theory of subject matter eligibility to guide such line drawing, based on the recognition that the Patent Act (for both eligibility and patentability) has always required and still requires creative, human invention in the application of such categorically excluded discoveries. So long as these basic discoveries continue to be treated as if already known, notwithstanding the contribution of the applicant in identifying the knowledge, it will improve efficiency and reduce patent system errors to rely on threshold eligibility determinations. Supplying clearer criteria to define the additional creativity required for eligibility will further reduce overall patent system burdens and will better direct investment, effort, invention, and disclosure towards more creative, patentable applications.
These categorical eligibility exclusions were justified historically on both deontological and utilitarian moral grounds. Prudence counsels retaining them, given the high social stakes involved, the lack of theoretical or empirical demonstration that competing innovation approaches are better, and the moral concerns that would be raised by their elimination. The article thus concludes with an exhortation to celebrate rather than to reluctantly embrace patentable subject matter categorical exclusions, their prior art status, and the line-drawing that eligibility determinations require, to better protect the public domain of science, nature, and ideas while simultaneously improving the patent system.
Full post as published by Legal Theory Blog on February 10, 2011 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Bush Administration
class action settlement ensures Medicaid beneficiaries can continue to purchase prescription drugs at minimum cost when they become eligible for Medicare.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment

Major new case on patent rights
UK Patent Office To Fast-Track Green Inventions
Sarnoff Memo Case Update: Third District Court Of Appeal Holds That Memo Is A Public Record
US Supreme Court Limits Patent Owners Control Over Downstream Use Of Their Inventions
US Supreme Court Review Of Bilski Could Reverberate Through Patent System







